
    
      The Safety of Skyvaricella Injection:

        -  The incidence of a chickenpox-like local rash (injection site) or chickenpox-like rash
           (disseminated) between 1 and 6 weeks after vaccination

        -  The incidence and severity of events (local and systemic) within 30 minutes after
           vaccination

        -  The incidence of expected systemic and local adverse events within 7 days after
           vaccination

        -  The incidence of serious adverse events and Unexpected adverse events within 6 weeks
           after vaccination The Immunogenicity of Skyvaricella Injection: seroconversion rate by
           Fluorescent antibody to membrane antigens (FAMA) test 6 weeks after investigational
           vaccination
    
  